Ugolini S, Mondor I, Parren P W, Burton D R, Tilley S A, Klasse P J, Sattentau Q J
Centre d'Immunologie de Marseille-Luminy, France.
J Exp Med. 1997 Oct 20;186(8):1287-98. doi: 10.1084/jem.186.8.1287.
Antibody-mediated neutralization of human immunodeficiency virus type-1 (HIV-1) is thought to function by at least two distinct mechanisms: inhibition of virus-receptor binding, and interference with events after binding, such as virus-cell membrane fusion. Here we show, by the use of a novel virus-cell binding assay, that soluble CD4 and monoclonal antibodies to all confirmed glycoprotein (gp)120 neutralizing epitopes, including the CD4 binding site and the V2 and V3 loops, inhibit the adsorption of two T cell line-adapted HIV-1 viruses to CD4+ cells. A correlation between the inhibition of virus binding and virus neutralization was observed for soluble CD4 and all anti-gp120 antibodies, indicating that this is a major mechanism of HIV neutralization. By contrast, antibodies specific for regions of gp120 other than the CD4 binding site showed little or no inhibition of either soluble gp120 binding to CD4+ cells or soluble CD4 binding to HIV-infected cells, implying that this effect is specific to the virion-cell interaction. However, inhibition of HIV-1 attachment to cells is not a universal mechanism of neutralization, since an anti-gp41 antibody did not inhibit virus-cell binding at neutralizing concentrations, implying activity after virus-cell binding.
抗体介导的对1型人类免疫缺陷病毒(HIV-1)的中和作用被认为至少通过两种不同机制发挥作用:抑制病毒与受体的结合,以及干扰结合后发生的事件,如病毒与细胞膜的融合。在此,我们通过使用一种新型的病毒-细胞结合试验表明,可溶性CD4以及针对所有已确认的糖蛋白(gp)120中和表位(包括CD4结合位点以及V2和V3环)的单克隆抗体,可抑制两种适应T细胞系的HIV-1病毒吸附到CD4+细胞上。对于可溶性CD4和所有抗gp120抗体,观察到病毒结合抑制与病毒中和之间存在相关性,这表明这是HIV中和的主要机制。相比之下,针对gp120中除CD4结合位点以外区域的抗体,对可溶性gp120与CD4+细胞的结合或可溶性CD4与HIV感染细胞的结合几乎没有或没有抑制作用,这意味着这种效应是病毒体与细胞相互作用所特有的。然而,抑制HIV-1与细胞的附着并非中和的普遍机制,因为一种抗gp41抗体在中和浓度下并未抑制病毒与细胞的结合,这意味着其活性在病毒与细胞结合之后。